Literature DB >> 18441445

Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome.

Iori Nagaoka1, Wataru Shimizu, Hideki Itoh, Satoshi Yamamoto, Tomoko Sakaguchi, Yuko Oka, Keiko Tsuji, Takashi Ashihara, Makoto Ito, Hidetada Yoshida, Seiko Ohno, Takeru Makiyama, Yoshihiro Miyamoto, Takashi Noda, Shiro Kamakura, Masaharu Akao, Minoru Horie.   

Abstract

BACKGROUND: In the LQT2 form of long QT syndrome (LQTS), mutation sites are reported to correlate with clinical phenotypes in Caucasians, but the relationship in Asian patients remains unknown. The present study was designed to determine whether the location of KCNH2 mutations would influence the arrhythmic risk in LQT2 patients. METHODS AND
RESULTS: In 118 genetically-confirmed LQT2 patients (69 families, 62 KCNH2 mutations), the ECG parameters, Schwartz scores, and the incidence of cardiac events, defined as syncope, aborted cardiac arrest, and sudden cardiac death, were evaluated. To examine the effect of mutation sites, the participants were divided accordingly: pore (n=56) and non-pore (n=62) groups. The corrected QTend interval was significantly greater in the pore than in the non-pore group (QTc; 522+/-63 ms vs 490+/-49 ms, p=0.002). In this study, the clinical course of each of the probands did not differ according to the mutation sites, whereas non-probands carrying the pore site mutation experienced their first cardiac events at significantly younger age than those with the non-pore site mutation (log-rank, p=0.0005).
CONCLUSIONS: In a Japanese LQT2 cohort, family members with the pore site mutation were at higher arrhythmic risk than those with the non-pore site mutation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441445     DOI: 10.1253/circj.72.694

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

Review 1.  Short and long QT syndromes: does QT length really matter?

Authors:  Jean-Philippe Couderc; Coeli M Lopes
Journal:  J Electrocardiol       Date:  2010 Sep-Oct       Impact factor: 1.438

2.  Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.

Authors:  Wataru Shimizu; Hisaki Makimoto; Kenichiro Yamagata; Tsukasa Kamakura; Mitsuru Wada; Koji Miyamoto; Yuko Inoue-Yamada; Hideo Okamura; Kohei Ishibashi; Takashi Noda; Satoshi Nagase; Aya Miyazaki; Heima Sakaguchi; Isao Shiraishi; Takeru Makiyama; Seiko Ohno; Hideki Itoh; Hiroshi Watanabe; Kenshi Hayashi; Masakazu Yamagishi; Hiroshi Morita; Masao Yoshinaga; Yoshiyasu Aizawa; Kengo Kusano; Yoshihiro Miyamoto; Shiro Kamakura; Satoshi Yasuda; Hisao Ogawa; Toshihiro Tanaka; Naotaka Sumitomo; Nobuhisa Hagiwara; Keiichi Fukuda; Satoshi Ogawa; Yoshifusa Aizawa; Naomasa Makita; Tohru Ohe; Minoru Horie; Takeshi Aiba
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

Review 3.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

Review 4.  Genetics of long QT syndrome.

Authors:  David J Tester; Michael J Ackerman
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

5.  Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation.

Authors:  Matthew R Stump; Qiuming Gong; Jonathan D Packer; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2012-09-03       Impact factor: 5.000

6.  Genotype-phenotype aspects of type 2 long QT syndrome.

Authors:  Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

7.  Position of premature termination codons determines susceptibility of hERG mutations to nonsense-mediated mRNA decay in long QT syndrome.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  Gene       Date:  2014-02-13       Impact factor: 3.688

8.  Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2.

Authors:  Briana L Sawyer; Martin Tristani-Firouzi; Layne E Wells; Matteo Vatta; Susan P Etheridge
Journal:  HeartRhythm Case Rep       Date:  2020-11-16

9.  Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia.

Authors:  Ryota Kitajima; Takeshi Aiba; Tsukasa Kamakura; Kohei Ishibashi; Mitsuru Wada; Yuko Inoue; Koji Miyamoto; Hideo Okamura; Takashi Noda; Satoshi Nagase; Yu Kataoka; Yasuhide Asaumi; Teruo Noguchi; Satoshi Yasuda; Kengo Kusano
Journal:  J Arrhythm       Date:  2017-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.